PubRank

Douglas E Wood

Author PubWeight™ 102.74‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003 10.40
2 Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012 8.71
3 Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med 2008 5.62
4 Non-small cell lung cancer. J Natl Compr Canc Netw 2010 3.93
5 Non-small cell lung cancer, version 2.2013. J Natl Compr Canc Netw 2013 2.56
6 Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg 2006 2.53
7 In vivo validation of 3'deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors. Clin Cancer Res 2002 2.48
8 Non-small cell lung cancer. J Natl Compr Canc Netw 2012 2.40
9 Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: new contrary data on prognostic role. Clin Cancer Res 2007 2.14
10 Minimally invasive resection of early lung cancers. Oncology (Williston Park) 2015 2.04
11 Management of centrally located non-small-cell carcinoma. Oncology (Williston Park) 2014 2.04
12 Racial disparities among patients with lung cancer who were recommended operative therapy. Arch Surg 2009 2.02
13 Imaging of subsquamous Barrett's epithelium with ultrahigh-resolution optical coherence tomography: a histologic correlation study. Gastrointest Endosc 2009 1.92
14 Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema. N Engl J Med 2003 1.79
15 Multi-modality mediastinal staging for lung cancer among medicare beneficiaries. J Thorac Oncol 2009 1.76
16 Gene expression analysis in a transgenic Caenorhabditis elegans Alzheimer's disease model. Neurobiol Aging 2003 1.72
17 Patient and surgical factors influencing air leak after lung volume reduction surgery: lessons learned from the National Emphysema Treatment Trial. Ann Thorac Surg 2006 1.71
18 Non-small cell lung cancer, version 1.2015. J Natl Compr Canc Netw 2014 1.71
19 Non-small cell lung cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw 2006 1.68
20 Predictors of operative mortality and cardiopulmonary morbidity in the National Emphysema Treatment Trial. J Thorac Cardiovasc Surg 2005 1.46
21 Relationship between non-small cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index. J Thorac Oncol 2008 1.39
22 Trends in the operative management and outcomes of T4 lung cancer. Ann Thorac Surg 2008 1.36
23 Counterpoint: should ultrasonographic endoscopy be the preferred modality for staging of lung cancer? No. Chest 2014 1.35
24 Gastric cancer. J Natl Compr Canc Netw 2010 1.35
25 Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes. Ann Thorac Surg 2008 1.28
26 Surgeon specialty and long-term survival after pulmonary resection for lung cancer. Ann Thorac Surg 2009 1.21
27 Management of pleural space infections: a population-based analysis. J Thorac Cardiovasc Surg 2006 1.19
28 Updated evaluation of the cost-effectiveness of lung volume reduction surgery. Chest 2007 1.16
29 Prospective randomized study evaluating a biodegradable polymeric sealant for sealing intraoperative air leaks that occur during pulmonary resection. Ann Thorac Surg 2004 1.13
30 Safety and efficacy of video-assisted versus conventional lung resection for lung cancer. J Thorac Cardiovasc Surg 2009 1.11
31 Traumatic injury to the trachea and bronchus. Thorac Surg Clin 2007 1.09
32 The Pseudocavitation Sign of Lung Adenocarcinoma: A Distinguishing Feature and Imaging Biomarker of Lepidic Growth. J Thorac Imaging 2015 1.06
33 Thymomas and thymic carcinomas: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2013 1.06
34 Health care utilization among surgically treated Medicare beneficiaries with lung cancer. Ann Thorac Surg 2009 1.05
35 Bronchial artery aneurysm refractory to transcatheter embolization. Ann Thorac Surg 2008 1.02
36 Malignant pleural mesothelioma. J Natl Compr Canc Netw 2012 1.01
37 Gastric Cancer Clinical Practice Guidelines. J Natl Compr Canc Netw 2006 1.00
38 Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2017 0.99
39 Treatment of heterogeneous emphysema using the spiration IBV valves. Thorac Surg Clin 2009 0.99
40 Clinical statement on the role of the surgeon and surgical issues relating to computed tomography screening programs for lung cancer. Ann Thorac Surg 2013 0.98
41 Pharmacodynamics and pharmacokinetics of the gamma-secretase inhibitor PF-3084014. J Pharmacol Exp Ther 2010 0.97
42 Bronchoscopic lung volume reduction in severe emphysema. Proc Am Thorac Soc 2008 0.96
43 The management of patients with stage IIIA non-small cell lung cancer with N2 mediastinal node involvement. J Natl Compr Canc Netw 2012 0.95
44 Variation in esophagectomy outcomes in hospitals meeting Leapfrog volume outcome standards. Ann Thorac Surg 2011 0.94
45 Esophageal cancer. J Natl Compr Canc Netw 2008 0.93
46 Pulmonary carcinoid tumors. Semin Thorac Cardiovasc Surg 2003 0.92
47 Relationship between non-small cell lung cancer fluorodeoxyglucose uptake at positron emission tomography and surgical stage with relevance to patient prognosis. Clin Cancer Res 2004 0.92
48 Esophageal Cancer Clinical Practice Guidelines. J Natl Compr Canc Netw 2006 0.87
49 The impact of fluorodeoxyglucose F 18 positron-emission tomography on the surgical staging of non-small cell lung cancer. J Thorac Cardiovasc Surg 2002 0.87
50 Temporal trends in the management of potentially resectable lung cancer. Ann Thorac Surg 2008 0.86
51 Reduction in airway complications after lung transplantation with novel anastomotic technique. Ann Thorac Surg 2011 0.82
52 Surgical management of T3 and T4 lung cancer. Clin Cancer Res 2005 0.82
53 Chronic traumatic and congenital diaphragmatic hernias: presentation and surgical management. Can Respir J 2002 0.82
54 Thymic malignancies. J Natl Compr Canc Netw 2010 0.81
55 Non-small cell lung cancer. J Natl Compr Canc Netw 2008 0.81
56 Design, synthesis, and in vivo characterization of a novel series of tetralin amino imidazoles as γ-secretase inhibitors: discovery of PF-3084014. Bioorg Med Chem Lett 2010 0.80
57 Airway obstruction complicating esophageal stent placement in two post-pneumonectomy patients. Ann Thorac Surg 2004 0.80
58 Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement. Clin Cancer Res 2005 0.79
59 Maximizing the benefit and minimizing the risks of lung cancer screening. J Thorac Imaging 2012 0.79
60 Expert opinion: United States Preventive Services Task Force recommendation on screening for lung cancer. J Thorac Imaging 2014 0.77
61 What is most important in improving outcomes after pulmonary lobectomy: the surgeon or the approach? Eur J Cardiothorac Surg 2012 0.76
62 Smoking Cessation, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2016 0.76
63 Lung volume reduction surgery: tempest in a teapot. J Thorac Cardiovasc Surg 2003 0.75
64 Surgeon specialty is associated with better outcomes: the facts speak for themselves. Ann Thorac Surg 2009 0.75
65 Rebuttal from drs Farjah and Wood. Chest 2014 0.75
66 Editorial comment: donation after circulatory death: an important expansion of donor organs for lung transplant patients. Eur J Cardiothorac Surg 2012 0.75
67 Optimizing lung transplant immunosuppression: beyond calcineurin inhibition. J Thorac Cardiovasc Surg 2003 0.75
68 Neurologic outcomes after cardiac operations. Ann Thorac Surg 2013 0.75
69 Diamide amino-imidazoles: a novel series of γ-secretase inhibitors for the treatment of Alzheimer's disease. Bioorg Med Chem Lett 2010 0.75
70 Utilization of cardiothoracic surgeons for operative penetrating thoracic trauma and its impact on clinical outcomes. Ann Thorac Surg 2013 0.75
71 Surgical and endoscopic palliation of advanced lung cancer. Surg Oncol Clin N Am 2011 0.75